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Abstract
Gall stones is a known entity in adults, but are considered uncommon in pediatric 
population, however in the recent years, mainly with wide spread use of ultraso-
nography, cholelithiasis in children is being frequently reported. Etiology of gall 
stones in children is not similar to adults. Pigment stones are the most frequently 
seen in children with hemolytic disease as the most common cause, however with 
the increase in obesity in children there is also rise in cholesterol stones. Many other 
causes like drugs, congenital hepatobiliary malformation and genetic causes are to 
be kept during evaluation of gall stones. Management of gall stones need a proper 
and timely work up for the causes of cholelithiasis is necessary in children. Surgical 
management with laparoscopic cholecystectomy is the treatment of choice in most 
of the cases however the timing of surgery should be optimized case to case basis.
Keywords: cholelithiasis in children, hemolytic anemia, pseudolithiasis
1. Introduction
Gall stones is a known entity in adults, but are considered uncommon in 
pediatric population with a prevalence of 0.13% to 0.2% [1] and no clear approach 
has been defined. However, in the recent years, mainly with wide spread use of 
ultrasonography, cholelithiasis in children is being frequently reported. Unlike 
adults the asymptomatic presentation is less likely in children (17–50%) [2, 3]. 
In children there is no difference in both genders pre pubertal, however there is 
female predominance after puberty. In some other cases, they are reported in 
association with clinical symptoms such as cholecystitis and cholangitis [4, 5]. 
Etiology of gall stones in children is not similar to adults. Many studies have shown 
haemolytic diseases are the most common causes of cholelithiasis in children 
[20–30%], followed by other cause like obesity, total parenteral nutrition, ileal 
disease or resection, congenital hepatobiliary diseases, use of ceftriaxone and 
idiopathic [6]. Other causes like metabolic syndrome, PFIC (progressive familial 
intrahepatic cholestasis), choledochal cyst, biliary cirrhosis, prematurity, necrotiz-
ing enterocolitis (NEC), Wilson disease, congenital heart diseases, cystic fibrosis, 
should also be considered.
2. Pathogenesis
Bile is mainly made up of water, bilirubin, cholesterol, bile pigments, and 
phospholipids. Imbalance in bile constituents [cholesterol, phospholipids, and bile 
salts] is the main cause of gallstone formation. Gallstone formation starts from the 
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sedimentation of cholesterol, bile pigments, and calcium salts which are insoluble 
[7]. By composition gallstones are divided into cholesterol gallstones or pigment 
stones. Unlike adults where mixed cholesterol gallstones are more common in 
adults, pigment stones are more common in children except adolescent girls.
2.1 Biliary sludge
Biliary sludge is mixture of mucin, calcium bilirubinate and cholesterol crystals, 
seen with prolonged fasting, sickle-cell disease, total parenteral nutrition, preg-
nancy and treatment with drugs like ceftriaxone, octreotide etc. [8]. Biliary sludge 
may resolve spontaneously or on removal of causative agent or may progress to 
gallstone development. Persistent sludge may give rise to complication like pancre-
atitis or cholangitis.
2.2 Cholesterol stones
Cholesterol supersaturation of bile with stasis predisposes to cholesterol gall-
stone formation, increased concentration of cholesterol also elevates the rate of 
crystallization leading to gallstone formation [9]. The cholesterol content is usually 
greater than 50%, with minimal calcium content, cholesterol stones are solitary, 
yellow-white, hard, crystalline, faceted, round, and smooth [10]. These stones 
are not radiopaque. Formation of cholesterol stones occurs due to hypersecretion 
of cholesterol, increased mucin production, and decreased gallbladder motility. 
Cholesterol stones are not commonly seen in children except adolescent girls. The 
risk factors for cholesterol stone formation in children include obesity, Hispanic 
ethnicity, family history, female sex (after puberty), and non-alcoholic fatty liver 
disease.
2.3 Pigment stones
Black pigment stones are formed due to supersaturation of bile with calcium 
bilirubinate [(to excess bilirubin) and are seen in haemolytic disorders and in 
association with total parenteral nutrition. These stones are commonly seen with 
hereditary haemolytic anaemias such as sickle cell disease, hereditary spherocy-
tosis and thalassemia. Pigment stones are also seen with cirrhosis, total parenteral 
nutrition, ileal disease and ceftriaxone use. Black pigment stones are black to brown 
in color, hard, shiny, and crystalline, multiple, size of less than 5 mm, composed 
mainly of bile pigment polymer (40%) followed by calcium carbonate or phos-
phate, salts, cholesterol and mucin glycoprotein. Persons with Gilbert syndrome, 
are at increased risk for black pigment gallstones due to increased bilirubin produc-
tion and a decrease in the bilirubin diphosphate-glucuronosyltransferase activity. 
Other etiologies for pigmented stones include medications such as ceftriaxone 
and octreotide. A decrease in the enterohepatic circulation of bile acids (seen with 
ileal disease or after ileal resection) is another predisposing factor for black stone 
formation. The mechanism responsible for gallstone formation in this setting is an 
interruption in the normal enterohepatic circulation of the endogenous bile salt 
pool [11].
Brown pigment stones are brown to orange in color, soft, greasy, multiple, and 
smooth composed mainly of calcium bilrubinate [60%] followed by, calcium pal-
mitate, stearate soaps, cholesterol and mucin glycoprotein. Brown pigment stones 
are distinctly seen in the setting of a bacterial/parasitic infection and biliary stasis. 
These are also seen in bile duct anomaly and cirrhosis. These are more often seen in 
the bile ducts than in the gall bladder [12].
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2.4 Hemolysis
Cholelithiasis is a well-known complication in pediatric patients with hemolytic 
anaemias like sickle cell disease, hereditary spherocytosis etc. The prevalence rate 
of gall stones in sickle cell disease ranges from 30 to 70% which increases progres-
sively with age and is usually not seen before the age of five [13]. The prevalence of 
pigment gallstones in sickle cell disease is around 10% in children under 10 years of 
age, which increases to 40% in those aged 10–18 years, and 50% in adults [14–16]. 
The prevalence of gallstones in hereditary spherocytosis is 10–20% in children, 
while it raises to 40% in adult population [17, 18]. Incidence of gall stones in 
thalassemia is low as compared to sickle cell disease [19, 20]. Thalassaemic who also 
has Gilbert’s syndrome genotype shows higher prevalence of gall stones [21, 22]. 
Whenever a child or adult with sickle cell disease experiences an episode of abdomi-
nal pain, cholelithiasis or biliary colic should be considered as differential diagnosis 
along with vaso-occlusive crisis. In sickle cell disease mutated red blood cells in the 
oxygenated form do not cause any problems, however in the deoxygenated form, 
they acquire sickle-like shape due to bond formation between replaced amino 
acid and globin molecules. This change in shape of red blood cells is reversible by 
reoxygenation however, changing shape again and again ruptures the cell mem-
brane, which leads to hemolysis [23]. The bilirubin which is produced by hemolysis, 
further conjugated in the liver and excreted in the intestine as urobilinogen which is 
further absorbed and excreted multiple times through the enterohepatic circulation 
of bile.in hemolysis the abundance of urobilinogen in the bile leads to precipitation 
which may become calcified, which if continuous leads to gall stone formation [24].
2.5 Ceftriaxone-associated biliary pseudolithiasis
Ceftriaxone, is a third-generation cephalosporin, and is commonly used as 
broad-spectrum antibiotic in children. Gall stones or biliary sludge has been 
reported as a complication of ceftriaxone treatment since long [25]. The incidence 
of ceftriaxone induced pseudolithiasis is variable from 15–45%, depending on dose, 
duration and predisposing host factors [26–30]. Since biliary lithiasis is reversible 
and disappears on discontinuation of drug it has been termed pseudolithiasis [31]. 
Ceftriaxone is 40% excreted via bile, as an anion it concentrates in bile easily and 
readily forms an insoluble salt with calcium [calcium-ceftriaxone] that precipi-
tates in gallbladder [32]. The predisposing risk factors for ceftriaxone induced 
biliary lithiasis are, high dose (>2 g or >200 mg/kg/day), long-term treatment, 
hypercalcemia, renal failure, and gallbladder stasis [33]. The mechanism of ceftri-
axone induced lithiasis is explained in Figure 1. Most cases of ceftriaxone induced 
pseudolithiasis are asymptomatic and detected on sonography. If cholelithiasis is 
symptomatic, discontinuation of drug is to be done but in incidentally detected 
asymptomatic cases of there is no need to stop drug. Usually these sludge/stones 
appear after one week of therapy and disappear after two weeks of discontinuation 
of therapy, however the time duration may vary with patient [34, 35].
2.6 Genetics
Various lithogenic gene variants have been found linked to formation of gall 
stones. Genome-wide association study (GWAS) have found a hepatobiliary choles-
terol transporter ABCG8 [p.D19H] as the most common genetic risk factor for gall 
stones [36]. Mutations in the ABCB4, ABCB11, CFTR [cystic fibrosis transmem-
brane conductance regulator] CYP7A1 gene causes gallstones by alteration in bile 
composition and secretion. Gall stone has been reported as initial symptom in early 
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childhood due to compound heterozygous mutation in ABCB4 gene (linked to pro-
gressive familial intrahepatic cholestasis type 3), these children are at risk of further 
developing decompensated chronic liver disease [37]. NPC1L1 [Niemann-Pick 
C1-Like 1] is responsible for intestinal and hepatobiliary cholesterol absorption. 
Functional studies showed that loss of function mutations of NPC1L1 are associated 
with decreased intestinal cholesterol absorption, changes in plasma low-density 
lipoprotein cholesterol levels decrease the reuptake of cholesterol from bile and thus 
promoting biliary cholesterol supersaturation. Gilbert promoter variant of the UDP 
glucuronosyl transferase gene [UGT1A1], appears to be an additional risk factor 
for gallstone risk. Studies have found that individuals predisposed to gall stone are 
characterized by an increased biliary output of cholesterol in the setting of rela-
tively low intestinal cholesterol absorption, pointing to enhanced whole-body sterol 
clearance. An ethnic gradient in the ratios of phytosterols to cholesterol precursors 
(highest in Germans) is also apparent which correlates negatively with susceptibil-
ity to gallstones [38].
2.7 Obesity
In adults the association between obesity with cholelithiasis is well known. 
A higher incidence of cholelithiasis has also been noticed in obese children [39]. 
Obese children and those with a higher mean BMI (>21.5) are at higher risk of 
cholelithiasis and more symptomatic compared to children with a normal BMI 
[9]. It is recommended that children with biliary symptoms or cholelithiasis, as 
well as unclear ultrasonography of the bile ducts with a BMI of 23 or more should 
routinely undergo MRCP to rule out choledocholithiasis. There is mechanical 
hypothesis for more prevalence of choledocholithiasis in obese children which 
postulates that higher body fat content in the abdominal wall causes greater intra-
abdominal pressure, resulting in external pressure on the wall of the gallbladder, 
this relatively higher pressure in the sub-hepatal region may results in a direct 
stimulus which further leads to dislodgment of the stone/sludge from the gall-
bladder into the extrahepatic biliary tree system, causing obstruction of the bile 
duct. The incidence of obesity in children rising in the some parts of world, the 
incidence of symptomatic cholelithiasis will also increase. Prevalence of choleli-
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2.8 Total parenteral nutrition and cholelithiasis
Total parenteral nutrition [TPN] impairs enterohepatic circulation and chole-
cystokinin induced gallbladder contraction resulting in biliary stasis, sludge and 
stones [41]. The risk of cholelithiasis increase with duration of TPN therapy, and 
if there is associated ileal resection or disease. Prolonged TPN therapy can lead to 
gallstones in 43% of children and it increases up to 64% in children with ileal resec-
tion or disease [42, 43]. Sludge formation occurs more rapidly in neonates with after 
a mean duration of 10 days of TPN infusion, as compared to adults where it takes 
more than 6 weeks.
3. Clinical features
Unlike adults, children are likely to be symptomatic, the prevalence of symp-
tomatic children is from 50–70% [44]. The most common clinical presentation is 
right upper quadrant abdominal pain [usually after meals] which may be radiating 
to the right shoulder, nausea, vomiting and occasionally fever. Symptoms are more 
seen if cholelithiasis is associated with complications like cholestasis, cholecystitis, 
and cholangitis, in these settings additional symptoms like icterus and Murphy’s 
sign can be seen. In infants, mostly cholelithiasis is asymptomatic and incidentally 
diagnosed on abdominal ultrasound.
3.1 Differential diagnosis of gall stones
The conditions mimicking the clinical features of cholelithiasis are gastroesoph-
ageal reflux disease, peptic ulcer disease, dyspepsia, acute acalculous cholecystitis, 
pancreatitis, hepatitis, irritable bowel syndrome, esophageal spasm, pneumonia, 
cardiac chest pain, and diabetic ketoacidosis and to be kept as differential diagnosis. 
A proper history and physical examination along with ultrasound imaging will help 
in making a final diagnosis.
4. Complications of gallstones
4.1 Acute calculous cholecystitis
Obstruction of the cystic duct by stones lead to inflammation of the gallblad-
der resulting in acute calculous cholecystitis. The obstruction causes gallbladder 
swelling followed by bile acid concentration, ischemia of gall bladder wall and 
occasionally, bacterial infection. Symptoms include pain similar to biliary colic with 
increased vomiting and fever. Patients usually have right upper quadrant tenderness 
on clinical examination and sometimes a palpable mass. Ultrasound can identify 
cholecystitis by presence of stone or sludge with gallbladder wall thickening and 
edema [double-wall sign], and pericholecystic fluid.
4.2 Common bile duct obstruction
The exact prevalence of choledocholithiasis in children is not known but they 
are uncommon in children. Common bile duct stones are mostly associated with 
gallstones except in few conditions like hemolysis where they can be primary. 
Presentation of choledocholithiasis include jaundice, acholic stools, and dark urine, 
sometimes presentation is with acute cholangitis, manifested by fever, jaundice, and 
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right upper quadrant pain. Choledocholithiasis should also be suspected in a patient 
with gallstones with raised conjugated bilirubin and/or a dilated common bile duct 
[as per age] on ultrasound.
4.3 Pancreatitis
Cholelithiasis is one of the leading cause of acute pancreatitis in adults, however 
the exact incidence of gallstone pancreatitis in children is not known. Patients with 
gallstone pancreatitis present with epigastric abdominal pain, nausea, and vomiting 
or jaundice. Sometimes gall stones are detected on evaluation of pancreatitis only. 
Ultrasound should be the first imaging modality followed by CT scan in doubtful 
cases. Biochemical investigation shows elevated serum amylase and lipase levels, 
and elevated conjugated serum bilirubin is often present.
5. Investigation
Ultrasound is the most accurate imaging study to evaluate for gall stones, can 
detect as small as 1.5 mm. On ultrasound gallstones appears as hyperechoic, single 
or multiple and characteristically cast an acoustic shadow in contrast biliary sludge 
appears echogenic on ultrasound, but does not cast an acoustic shadow. Both 
sensitivity and specificity of ultrasonography is 95% for gall stones, but it is low for 
stones in common bile duct [45]. Cholescintigraphy, with Tc 99 m labeled diisopro-
pyl iminodiacetic acid [DISIDA], is the most accurate method of diagnosing acute 
cholecystitis, non-visualization of the gallbladder in an otherwise patent biliary 
system suggests acute cholecystitis. Magnetic resonance cholangiopancreatography 
(MRCP) is being used increasingly to investigate complicated gallstone disease 
and choledocholithiasis and for delineating pancreatic and biliary tract anatomy. 
Endoscopic retrograde cholangiopancreatography (ERCP) can be done for both 
diagnostic and therapeutic in common bile duct stones. Endoscopic ultrasound can 
be used for diagnosis in children with complicated biliary stone disease CT scan do 
not have much role in diagnosis of gall stones [46, 47]. There are no specific labora-
tory tests in diagnosing cholelithiasis, some blood tests are required for making 
etiological diagnosis and to rule out complications. These include Complete blood 
count, liver function tests, lipid profile [serum cholesterol (LDL, HDL, VLDL) and 
serum triglycerides], hemolytic profile [reticulocytes, osmotic fragility, quan-
titative glucose 6 phosphate dehydrogenase (G6PD) measurement, hemoglobin 
electrophoresis, direct coombs test], next generation sequencing (if genetic cause 
suspected) and sweat chloride test (if cystic fibrosis suspected) and serum amylase 
and lipase, if pancreatitis is suspected.
6. Management
Management of cholelithiasis is affected by several contributing factors, such 
as type of stone, anatomical status of gallstone, rate of symptoms in the child, 
underlying anatomical malformations, other underlying disease, inflammatory 
changes of the biliary system, and age of the child. Children with gallstones should 
be divided into two groups, symptomatic and asymptomatic. Symptomatic and 
complicated gallstones need cholecystectomy [48]. Gallstones which float in the 
gallbladder, having a diameter of less than 10 mm and are diagnosed incidentally 
in asymptomatic children, should be investigated for haemolytic diseases and 
underlying disorders and need to be treated after diagnosis. In infants mostly, 
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cholelithiasis resolves after several months of monitoring. However, cholelithiasis 
is not usually resolved spontaneously in older children. In a prospective study of 
children with nonpigmented gallstones it was found that, 50% remained or became 
asymptomatic, 32% experienced definite improvement in symptoms, and 18% 
had continued symptoms but none had any biliary complications [49]. The risk 
of subsequent hospital admission in children and adolescents with cholelithiasis 
increases by 5% for every 10 days [50]. Also, one fourth of children with gall stones, 
presents directly with complications [51]. Therapy with UDCA is recommended in 
asymptomatic patients with cholesterol stones [52]. However, the role of dissolu-
tion therapy in the management of gallstones in children remains to be defined, the 
use of UDCA therapy is restricted due to the long course of treatment, differential 
outcome, and the risk of side-effects such as diarrhea and liver dysfunction [53]. 
Gallstones when located in the common bile duct or around the pupillary sphincter, 
can cause cholangitis, obstruction of bile flow, and jaundice, stone removal should 
be done urgently tp relieve obstruction. In centres where pediatric ERCP is offered 
the endoscopic approach to relieve obstruction is safe and effective, if not laparo-
scopic exploration is also safe and effective alternative. In recent years, laparoscopic 
cholecystectomy (LC) has become the treatment of choice in the surgical manage-
ment of children with cholelithiasis. Approach for mnagemement of gall stones in 
children given in Figure 2. LC is less invasive, has lower morbidity and mortality 
with shorter hospital stay in comparison to conventional open cholecystectomy 
[54]. Extracorporeal shock-wave lithotripsy is another therapeutic method, in 
selective cases like when the patient is asymptomatic or with the radiolucent 
gallstone.
In children receiving TPN especially longer duration should be assessed for 
gallstones. On discontinuation of TPN regimen and start of oral diet leads to estab-
lishment of bile flow which resolves bile sedimentation. TPN needs to be continued 
in cases where enteral feeding cant be done such as intestinal pseudo-obstruction 
or short bowel syndrome, in these patients therapeutic cholecystectomy should be 
done in presence of gallstones [55].
The approach to cholelithiasis in infancy is different as spontaneous resolu-
tion has been reported in a significant proportion of cases (cholelithiasis ̴50% and 
choledocholithiasis ̴ 30%). Spontaneous resolution within 6 months is more common 
Figure 2. 
Approach for management of gallstones in children.
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with idiopathic and or asymptomatic gallstones than in patients with known predis-
posing factors. Cholecystectomy is indicated for symptomatic cholelithiasis, asymp-
tomatic cholelithiasis persisting beyond 12 months and radiopaque calculi [56, 57].
6.1 Management of cholelithiasis in hemolytic disease
In children with hemolytic anaemias, screening for gall stones with Ultrasound 
is recommended from 5 years of age. Screening is also recommended before sple-
nectomy as both splenectomy and cholecystectomy to be done in single setting in 
presence of gallstones [58, 59]. In sickle-cell disease, prophylactic cholecystectomy 
is recommended even for asymptomatic gallstones as it is difficult to differentiate 
an acute abdominal crisis from acute cholecystitis, and the morbidity and mortality 
of emergency cholecystectomy in acute crisis is much higher than in elective cho-
lecystectomy [58]. To avoid sickling during the perioperative period hypotension, 
hypoxia, hypothermia, dehydration, and acidosis should be avoided and hemoglo-
bin S should be kept below 30% and total hemoglobin should be at least of 11 g/dL 
[60, 61]. Many studies recommended LC in asymptomatic patients with hemolytic 
diseases to avoid the complications of urgent cholecystectomy and the chance of 
gallstone complications among the asymptomatic patients is upto 50% within 5 year 
of diagnosis [62]. Inflammation and infection of the gallbladder also increases the 
chance of a hemolytic crisis. Oral hydroxyurea reduces the frequency of cholelithia-
sis in some haemolytic diseases, such as thalassemia intermedia or major.
7. Prevention of gall stones
Gallstones are formed due to interaction of multiple factors like genetic, ana-
tomical, systemic and metabolic abnormalities. However, there are some preventive 
factors especially for cholesterol gallstones which include regular diet, lifestyle, 
physical exercise, and intake of vitamin C. Lifestyle should include physical activ-
ity, ideal weight maintenance and weight reduction among overweight and obese 
children to prevent gall stones. It has been found that physical activity decreases 
the risk of symptomatic stones by about 30–70%. Regular exercise reduces insulin 
levels, insulin resistance, triglyceridemia, and fatty acid-dependent hypersecretion 
of gallbladder mucin. Also, physical activity has a prokinetic effect on the intestine 
and cholecystokinin-dependent gallbladder contraction. High fiber and regular 
eating pattern diets decrease hydrophobic bile acids, and reduces gallbladder stasis 
by increasing gallbladder emptying. Regular vitamin C supplementation or diet 
containing higher amount of vitamin C have a protective effect on gallstone forma-
tion. Situations associated with rapid loss of weight like very low-calorie diet or 
bariatric surgery, temporary oral UDCA may be recommended to prevent gall stone 
formation as the risk of cholelithiasis is much higher in these situations. There is 
also some role of fish oil polyunsaturated fatty acids on prevention of gall stones 
in obese patients. In sickle cell anemia hydroxyurea has been found to have some 
preventive role for pigment stones.
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